Akt1/2 kinase inhibitor is an Isozyme selective Akt1/2 kinase inhibitor. In in vitro kinase assays, this shows IC50 = 58 nM, 210 nM, and 2.12 mM for Akt1, Akt2, and Akt3. The inhibition appears to be pleckstrin homology (PH) domain-dependent and the Akt1/2 kinase inhibitor has no inhibitory effect against PH domain-lacking Akts, or other closely related AGC family kinases, PKA, PKC, and SGK, even at concentrations as high as 50 μM.
1. Zhao, Z. 2005. Bioorg. Med. Chem. Lett. 15(4): 905-909. PMID: 15686884 2. Barnett, S.F. 2005. Biochem. J. 385(Pt 2): 399-408. PMID: 15456405
See how others have used Akt1/2 kinase inhibitor Inhibitor. Click on the entry to view the PubMed entry .
PMID: # 30886861 Tsai, FM.|Li, CH.|Wang, LK.|Chen, ML.|Lee, MC.|Lin, YY.|Wang, CH.| et al. 2019. Biomed Res Int. 2019: 6360503.
PMID: # 29992246 Wang, D. et al. 2018. Endocrinology. 159: 3132-3142.
PMID: # 32427102 Elife. 9:
PMID: # 31432194 Mol Med Rep. 20: 3719-3727.